Clinical Trial Update: Bioequivalence Study With Clinical Endpoint for Diclofenac Sodium Topical Gel 1% [Phase 3]

View source ↗

Summary

Phase 3 bioequivalence study with clinical endpoint for diclofenac sodium topical gel 1% has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Osteoarthritis

Drugs mentioned

• diclofenac sodium topical gel, 1% (diclofenac sodium topical gel, 1%)

Snippet

Sponsor: Akorn, Inc. | Conditions: Osteoarthritis, Knee | Phase 3 | Status: COMPLETED | Results posted: 2021-02-26